i
CDC recommendations for influenza antiviral medications remain unchanged
-
02/09/2012
Details:
-
Journal Article:HAN
-
Corporate Authors:
-
Description:February 09, 2012, 15:00 EST
CDCHAN-00324-ADV-N
A recent review of randomized clinical trial data for the influenza neuraminidase inhibitor antiviral medications, and two related commentaries, raised questions about the value of antiviral medications for the prevention and treatment of influenza. On February 7, 2012, the Centers for Disease Control and Prevention (CDC) posted a "Have You Heard?" piece in response. The CDC response states "After careful consideration of all available evidence, CDC guidance on the use of antiviral medications remains unchanged." CDC continues to recommend the use of neuraminidase inhibitor antiviral drugs (oral oseltamivir and inhaled zanamivir) as an important adjunct in the prevention and treatment of influenza.
-
Subjects:
-
Series:
-
Document Type:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
Supporting Files
-
No Additional Files
More +